Public Services Committee
Homecare medicines services: an opportunity lost

4th Report of Session 2022-23 - published 16 November 2023 - HL Paper 269



Chapter 1: Introduction

What are homecare medicines services?

Figure 1: Homecare from hospital to patient

Models of delivery

Figure 2: NHS-funded homecare

Figure 3: Manufacturer-funded homecare arrangements

Other work

2011 Hackett review

NHS England research

Governance bodies

Table 1: Relevant bodies within homecare

Chapter 2: The problem

Patient experience

Box 1: Experiences of delays

Effect on patients

Box 2: Quotes illustrating the detrimental impact of poor service

Impact on the NHS

Box 3: Clinician experience

Chapter 3: Transparency

The scale of the problem: competing views

Table 2: Quotes illustrating competing views

Performance data


Chapter 4: Purchasing

Available support

Lack of expertise


Chapter 5: Regulators



Appetite for enforcement

Chapter 6: State of the market

Systems interoperability

Electronic prescribing

Chapter 7: Who is responsible?

Political ownership

Accountability and oversight

Patient recourse

A responsible person

Chapter 8: Next steps

Summary of conclusions and recommendations

Appendix 1: List of Members and declarations of interest

Appendix 2: List of witnesses

Appendix 3: Glossary

Evidence is published online at and available for inspection at the Parliamentary Archives (020 7219 3074).

Q in footnotes refers to a question in oral evidence.

© Parliamentary copyright 2023